Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term growth. Found 68 abstracts

no pagination
Betancourt A, Mobley JA, Wang J, Jenkins S, Chen DQ, Kojima K, Russo J, Lamartiniere CA. Alterations in the Rat Serum Proteome Induced by Prepubertal Exposure to Bisphenol A and Genistein. Journal of Proteome Research. 2014 Mar;13(3):1502-14.   PMCID: PMC 3993963
Chow HY, Jubb AM, Koch JN, Jaffer ZM, Stepanova D, Campbell DA, Duron SG, O'Farrell M, Cai KQ, Klein-Szanto AJ, Gutkind JS, Hoeflich KP, Chernoff J. p21-Activated Kinase 1 Is Required for Efficient Tumor Formation and Progression in a Ras-Mediated Skin Cancer Model. Cancer Research. 2012 Nov;72(22):5966-75.   PMCID: PMC3500416
Crispen PL, Soljic A, Stewart G, Kutikov A, Davenport D, Uzzo RG. Enhancing Renal Tumors in Patients with Prior Normal Abdominal Imaging: Further Insight into the Natural History of Renal Cell Carcinoma. Journal of Urology. 2012 Oct;188(4):1089-93.   PMCID: PMC 3815634
Martin LP, Kozloff MF, Herbst RS, Samuel TA, Kim S, Rosbrook B, Tortorici M, Chen Y, Tarazi J, Olszanski AJ, Rado T, Starr A, Cohen RB. Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours. British Journal of Cancer. 2012 Oct;107(8):1268-76.
Martin LP, Kozloff MF, Herbst RS, Samuel TA, Kim S, Rosbrook B, Tortorici M, Chen Y, Tarazi J, Olszanski AJ, Rado T, Starr A, Cohen RB. Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours. British Journal of Cancer. 2012 Oct;107(8):1268-76.   PMCID: PMC3494424
Rich TA, Winter K, Safran H, Hoffman JP, Erickson B, Anne PR, Myerson RJ, Cline-Burkhardt VJ, Perez K, Willett C. Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer. Oncotargets and Therapy. 2012 Jan;5:161-70.   PMCID: PMC3430391
Rizzolio F, Lucchetti C, Caligiuri I, Marchesi I, Caputo M, Klein-Szanto A, Bagella L, Castronovo M, Giordano A. Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1. Cell death and differentiation. 2012 Jul;19(7):1152-61.   PMCID: PMC3374078
Shi Z, Yang WM, Chen LP, Yang DH, Zhou Q, Zhu J, Chen JJ, Huang RC, Chen ZS, Huang RP. Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production. Breast Cancer Research and Treatment. 2012 Oct;135(3):737-47.
Cash TP, Gruber JJ, Hartman TR, Henske EP, Simon MC. Loss of the Birt-Hogg-Dube tumor suppressor results in apoptotic resistance due to aberrant TGF beta-mediated transcription. Oncogene. 2011 Jun;30(22):2534-46.   PMCID: PMC3109270
Fratamico PM, Wang SY, Yan XH, Zhang W, Li YS. Differential Gene Expression of E. coli O157:H7 in Ground Beef Extract Compared to Tryptic Soy Broth. Journal of Food Science. 2011 Jan;76(1):M79-M87.   PMCID: not NIH funded
Huang J, Zhang L, Greshock J, Colligon TA, Wang Y, Ward R, Katsaros D, Lassus H, Butzow R, Godwin AK, Testa JR, Nathanson KL, Gimotty PA, Coukos G, Weber BL, Degenhardt Y. Frequent Genetic Abnormalities of the PI3K/AKT Pathway in Primary Ovarian Cancer Predict Patient Outcome. Genes Chromosomes & Cancer. 2011 Aug;50(8):606-18.   PMCID: PMC3110626
Makhov PB, Golovine KV, Kutikov A, Canter DJ, Rybko VA, Roshchin DA, Matveev VB, Uzzo RG, Kolenko VM. Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells. Carcinogenesis. 2011 Dec;32(12):1773-81.   PMCID: PMC3220607
Sparano JA, Goldstein LJ, Childs BH, Shak S, Brassard D, Badve S, Baehner FL, Bugarini R, Rowley S, Perez EA, Shulman LN, Martino S, Davidson NE, Kenny PA, Sledge GW, Gray R. Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer. Clinical Cancer Research. 2011 Nov;17(22):7194-203.   PMCID: PMC3570203
Betancourt AM, Eltoum IA, Desmond RA, Russo J, Lamartiniere CA. In Utero Exposure to Bisphenol A Shifts the Window of Susceptibility for Mammary Carcinogenesis in the Rat. Environmental Health Perspectives. 2010 Nov;118(11):1614-9.   PMCID: PMCID: PMC2974702
Bruno T, Desantis A, Bossi G, Di Agostino S, Sorino C, De Nicola F, Iezzi S, Franchitto A, Benassi B, Galanti S, La Rosa F, Floridi A, Bellacosa A, Passananti C, Blandino G, Fanciulli M. Che-1 Promotes Tumor Cell Survival by Sustaining Mutant p53 Transcription and Inhibiting DNA Damage Response Activation. Cancer cell. 2010 Aug;18(2):122-34.   PMCID: not NIH funded
Mego M, Mani SA, Cristofanilli M. Molecular mechanisms of metastasis in breast cancer-clinical applications. Nature Reviews Clinical Oncology. 2010 Dec;7(12):693-701.
Smith ER, Cai KQ, Smedberg JL, Ribeiro MM, Rula ME, Slater C, Godwin AK, Xu XX. Nuclear Entry of Activated MAPK Is Restricted in Primary Ovarian and Mammary Epithelial Cells. Plos One. 2010 Feb;5(2).   PMCID: PMC2823791
Akino T, Hida K, Hida Y, Tsuchiya K, Freedman D, Muraki C, Ohga N, Matsuda K, Akiyama K, Harabayashi T, Shinohara N, Nonomura K, Klagsbrun M, Shindoh M. Cytogenetic Abnormalities of Tumor-Associated Endothelial Cells in Human Malignant Tumors. American Journal of Pathology. 2009 Dec;175(6):2657-67.   PMCID: PMC2789618
Cohen RB, Jones SF, Aggarwal C, von Mehren M, Cheng J, Spigel DR, Greco FA, Mariani M, Rocchetti M, Ceruti R, Comis S, Laffranchi B, Moll J, Burris HA. A Phase I Dose-Escalation Study of Danusertib (PHA-739358) Administered as a 24-Hour Infusion with and without Granulocyte Colony-Stimulating Factor in a 14-Day Cycle in Patients with Advanced Solid Tumors. Clinical Cancer Research. 2009 Nov;15(21):6694-701.
Curley MD, Therrien VA, Cummings CL, Sergent PA, Koulouris CR, Friel AM, Roberts DJ, Seiden MV, Scadden DT, Rueda BR, Foster R. CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer. Stem Cells. 2009 Dec;27(12):2875-83.   PMCID: not NIH funded
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term growth

growth expression breast-cancer cancer survival in-vivo colorectal-cancer mutations inhibitor overexpression progression 1990 lkman j-journal of the national cancer institute-v82-p4 trial combination tumor-suppressor gene ag-013736 cell lung-cancer stem-cells metastatic breast-cancer phosphorylation receptors pharmacokinetics kinase paclitaxel axitinib-docetaxel-capecitabine-solid tumours identification bevacizumab gene-expression therapy carcinoma pancreatic-cancer interleukin-6 masses risk checkpoint disposition squamous-cell carcinomas akt contribute concurrent capecitabine tumorigenesis breaks import fetal active surveillance peptide progenitor cells epithelial ovarian-cancer solid tumors profile phase-iii trial taxol genistein cell-cycle arrest aurora kinase inhibitor basal-like subtype signaling pathways retinoic acid ap-2-alpha genomic instability stroma gland down-regulation model breast-cancer cells serum-levels polymerase chain-reaction coatings developing drosophila eye autocrine production carcinogenesis estrogen glioblastoma serum protein farnesyltransferase radiation-therapy cytokines statistical-model bhd gene database search potent paclitaxel pancreas cancer-gemcitabine-irradiation array technology pp2a circulating tumor-cells 1000 bchy a-clin canc res-v16-p5351 pak protein-kinases hematopoietic stem carcinomas translocation 1993 oy h-cancer-v71-p3774 BPA chemotherapy resistance copy number transcription factor ap-2 superfamily angiogenesis in-vitro interacts transport yolk-sac conditional expression tumors monocyte chemotactic protein-1 mesenchymal transition Human CD133-Ovarian cancer-Cancer stem cells-Tumor-initiating cells Pin1 pRb phosphorylation-CDK-cell cycle control small-molecule inhibitor paclitaxel proteomics bh3-only protein bim mtor activation proteins outcomes hzip1 microbial survival prolyl-isomerase pin1 renal-cell carcinoma erk2 comparative genomic hybridization meat safety protein positive cells gene-expression profiles tandem mass-spectrometry apoptosis BHD-Bim-TGF beta-mTOR gain escherichia-coli inhibition watchful waiting kidney neoplasms-disease progression tnf-alpha differentiation E coli O157:H7 mammary-glands k-ras migration stress organization proliferation activator protein-2 cell proliferation bisphenol A-endocrine disruptors-mammary cancer-susceptibility vivo protein-kinase phase-i trial methylation mek inhibitor pd0325901 kidney cancer molecular biology o157h7 p73 induces apoptosis
Last updated on Monday, November 05, 2018